1052 related articles for article (PubMed ID: 29705240)
21. Hepatocyte-specific deletion of Nlrp6 in mice exacerbates the development of non-alcoholic steatohepatitis.
Huang C; Liu Q; Tang Q; Jing X; Wu T; Zhang J; Zhang G; Zhou J; Zhang Z; Zhao Y; Huang H; Xia Y; Yan J; Xiao J; Li Y; He J
Free Radic Biol Med; 2021 Jun; 169():110-121. PubMed ID: 33857628
[TBL] [Abstract][Full Text] [Related]
22. Hepatocyte vitamin D receptor regulates lipid metabolism and mediates experimental diet-induced steatosis.
Bozic M; Guzmán C; Benet M; Sánchez-Campos S; García-Monzón C; Gari E; Gatius S; Valdivielso JM; Jover R
J Hepatol; 2016 Oct; 65(4):748-757. PubMed ID: 27245430
[TBL] [Abstract][Full Text] [Related]
23. Macrophage p38α promotes nutritional steatohepatitis through M1 polarization.
Zhang X; Fan L; Wu J; Xu H; Leung WY; Fu K; Wu J; Liu K; Man K; Yang X; Han J; Ren J; Yu J
J Hepatol; 2019 Jul; 71(1):163-174. PubMed ID: 30914267
[TBL] [Abstract][Full Text] [Related]
24. Hypoxia-inducible factor 2α drives hepatosteatosis through the fatty acid translocase CD36.
Rey E; Meléndez-Rodríguez F; Marañón P; Gil-Valle M; Carrasco AG; Torres-Capelli M; Chávez S; Del Pozo-Maroto E; Rodríguez de Cía J; Aragonés J; García-Monzón C; González-Rodríguez Á
Liver Int; 2020 Oct; 40(10):2553-2567. PubMed ID: 32432822
[TBL] [Abstract][Full Text] [Related]
25. Internalization of modified lipids by CD36 and SR-A leads to hepatic inflammation and lysosomal cholesterol storage in Kupffer cells.
Bieghs V; Verheyen F; van Gorp PJ; Hendrikx T; Wouters K; Lütjohann D; Gijbels MJ; Febbraio M; Binder CJ; Hofker MH; Shiri-Sverdlov R
PLoS One; 2012; 7(3):e34378. PubMed ID: 22470565
[TBL] [Abstract][Full Text] [Related]
26. The role of hepassocin in the development of non-alcoholic fatty liver disease.
Wu HT; Lu FH; Ou HY; Su YC; Hung HC; Wu JS; Yang YC; Wu CL; Chang CJ
J Hepatol; 2013 Nov; 59(5):1065-72. PubMed ID: 23792031
[TBL] [Abstract][Full Text] [Related]
27. Deficiency of WTAP in hepatocytes induces lipoatrophy and non-alcoholic steatohepatitis (NASH).
Li X; Ding K; Li X; Yuan B; Wang Y; Yao Z; Wang S; Huang H; Xu B; Xie L; Deng T; Chen XW; Chen Z
Nat Commun; 2022 Aug; 13(1):4549. PubMed ID: 35927268
[TBL] [Abstract][Full Text] [Related]
28. Murine CD103
Heier EC; Meier A; Julich-Haertel H; Djudjaj S; Rau M; Tschernig T; Geier A; Boor P; Lammert F; Lukacs-Kornek V
J Hepatol; 2017 Jun; 66(6):1241-1250. PubMed ID: 28108233
[TBL] [Abstract][Full Text] [Related]
29. CCN1 promotes hepatic steatosis and inflammation in non-alcoholic steatohepatitis.
Ju L; Sun Y; Xue H; Chen L; Gu C; Shao J; Lu R; Luo X; Wei J; Ma X; Bian Z
Sci Rep; 2020 Feb; 10(1):3201. PubMed ID: 32081971
[TBL] [Abstract][Full Text] [Related]
30. Lactoferrin attenuates fatty acid-induced lipotoxicity via Akt signaling in hepatocarcinoma cells.
Morishita S; Tomita K; Ono T; Murakoshi M; Saito K; Sugiyama K; Nishino H; Kato H
Biochem Cell Biol; 2015 Dec; 93(6):566-73. PubMed ID: 26335364
[TBL] [Abstract][Full Text] [Related]
31. Hepatocyte glutathione S-transferase mu 2 prevents non-alcoholic steatohepatitis by suppressing ASK1 signaling.
Lan T; Hu Y; Hu F; Li H; Chen Y; Zhang J; Yu Y; Jiang S; Weng Q; Tian S; Ma T; Yang G; Luo D; Wang L; Li K; Piao S; Rong X; Guo J
J Hepatol; 2022 Feb; 76(2):407-419. PubMed ID: 34656650
[TBL] [Abstract][Full Text] [Related]
32. Non-Alcoholic Fatty Liver Disease.
Engin A
Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
[TBL] [Abstract][Full Text] [Related]
33. Pyruvate dehydrogenase kinase 4 mediates lipogenesis and contributes to the pathogenesis of nonalcoholic steatohepatitis.
Zhang M; Zhao Y; Li Z; Wang C
Biochem Biophys Res Commun; 2018 Jan; 495(1):582-586. PubMed ID: 29128353
[TBL] [Abstract][Full Text] [Related]
34. The methyltransferase METTL3 negatively regulates nonalcoholic steatohepatitis (NASH) progression.
Li X; Yuan B; Lu M; Wang Y; Ding N; Liu C; Gao M; Yao Z; Zhang S; Zhao Y; Xie L; Chen Z
Nat Commun; 2021 Dec; 12(1):7213. PubMed ID: 34893641
[TBL] [Abstract][Full Text] [Related]
35. Attenuated lipotoxicity and apoptosis is linked to exogenous and endogenous augmenter of liver regeneration by different pathways.
Weiss TS; Lupke M; Ibrahim S; Buechler C; Lorenz J; Ruemmele P; Hofmann U; Melter M; Dayoub R
PLoS One; 2017; 12(9):e0184282. PubMed ID: 28877220
[TBL] [Abstract][Full Text] [Related]
36. Hepatocyte-specific Keap1 deletion reduces liver steatosis but not inflammation during non-alcoholic steatohepatitis development.
Ramadori P; Drescher H; Erschfeld S; Schumacher F; Berger C; Fragoulis A; Schenkel J; Kensler TW; Wruck CJ; Trautwein C; Kroy DC; Streetz KL
Free Radic Biol Med; 2016 Feb; 91():114-26. PubMed ID: 26698665
[TBL] [Abstract][Full Text] [Related]
37. Plasma membrane phospholipase A2 controls hepatocellular fatty acid uptake and is responsive to pharmacological modulation: implications for nonalcoholic steatohepatitis.
Stremmel W; Staffer S; Wannhoff A; Pathil A; Chamulitrat W
FASEB J; 2014 Jul; 28(7):3159-70. PubMed ID: 24719358
[TBL] [Abstract][Full Text] [Related]
38. Oxidized high-density lipoprotein promotes CD36 palmitoylation and increases lipid uptake in macrophages.
Zhang Y; Dong D; Xu X; He H; Zhu Y; Lei T; Ou H
J Biol Chem; 2022 Jun; 298(6):102000. PubMed ID: 35500650
[TBL] [Abstract][Full Text] [Related]
39. TLR9 is up-regulated in human and murine NASH: pivotal role in inflammatory recruitment and cell survival.
Mridha AR; Haczeyni F; Yeh MM; Haigh WG; Ioannou GN; Barn V; Ajamieh H; Adams L; Hamdorf JM; Teoh NC; Farrell GC
Clin Sci (Lond); 2017 Aug; 131(16):2145-2159. PubMed ID: 28687713
[TBL] [Abstract][Full Text] [Related]
40. Hepatocyte specific deletion of c-Met leads to the development of severe non-alcoholic steatohepatitis in mice.
Kroy DC; Schumacher F; Ramadori P; Hatting M; Bergheim I; Gassler N; Boekschoten MV; Müller M; Streetz KL; Trautwein C
J Hepatol; 2014 Oct; 61(4):883-90. PubMed ID: 24845607
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
